Negative regulation of quinone reductase 2 by resveratrol in cultured vascular smooth muscle cells

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 12, 2008, Pages 1419-1425

  Cai, Jing Bo ^a   Zhang, Zhi Hua ^a   Xu, Dong Jie ^a   Qian, Zhi Yong ^a   Wang, Zhi Rong ^b   Huang, Yuan Zhu ^a   Zou, Jian Gang ^a   Cao, Ke Jiang ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Lentiviral vector; Quinone reductase type 2 (NQO2); Resveratrol; Resveratrol targeting protein; RNA interference; Vascular smooth muscle cells

Indexed keywords

LENTIVIRUS VECTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); RESVERATROL; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG TARGETING; GENE EXPRESSION; HEART PROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; REAL TIME POLYMERASE CHAIN REACTION; RED WINE; RNA INTERFERENCE; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANIMALS; AORTA, THORACIC; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENZYME INHIBITORS; MALE; MUSCLE, SMOOTH, VASCULAR; QUINONE REDUCTASES; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; STILBENES; TIME FACTORS;

EID: 55349091060     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.05006.x     Document Type: Article

References (34)

1. Panagiotakos DB, Chrysohoou C, Pitsavos C et al. Forty-years (1961-2001) of all-cause and coronary heart disease mortality and its determinants: The Corfu cohort from the Seven Countries Study. Int. J. Cardiol. 2003 90 : 73 9.
2. Centers for Disease Control Prevention (CDC). Mortality from coronary heart disease and acute myocardial infarction: United States, 1998. MMWR 2001 50 : 90 3.
3. Park SW, Lee CW, Hong MK et al. Randomized comparison of coronary stenting with optimal balloon angioplasty for treatment of lesions in small coronary arteries. Eur. Heart J. 2000 21 : 1785 9.
4. Brophy JM, Belisle P, Joseph L. Evidence for use of coronary stents: A hierarchical bayesian meta-analysis. Ann. Intern. Med. 2003 138 : 777 86.
5. Kearney M, Pieczek A, Haley L et al. Histopathology of in-stent restenosis in patients with peripheral artery disease. Circulation 1997 95 : 1998 2002.
6. Karsch KR, Haase KK, Wehrmann M, Hassenstein S, Hanke H. Smooth muscle cell proliferation and restenosis after stand alone coronary excimer laser angioplasty. J. Am. Coll. Cardiol. 1991 17 : 991 4.
7. You XM, Mungrue IN, Kalair W et al. Conditional expression of a dominant-negative c-Myb in vascular smooth muscle cells inhibits arterial remodeling after injury. Circ. Res. 2003 92 : 314 21.
8. Bennett MR, O'Sullivan M. Mechanisms of angioplasty and stent restenosis: Implications for design of rational therapy. Pharmacol. Ther. 2001 91 : 149 66.
9. Yasumoto H, Kim S, Zhan Y et al. Dominant negative c-jun gene transfer inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in rats. Gene Ther. 2001 8 : 1682 9.
10. Mizutani K, Ikeda K, Yamori Y. Resveratrol inhibits AGEs-induced proliferation and collagen synthesis activity in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. Biochem. Biophys. Res. Commun. 2000 274 : 61 7.
11. Poussier B, Cordova AC, Becquemin JP, Sumpio BE. Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosis. J. Vasc. Surg. 2005 42 : 1190 7.
12. Mnjoyan ZH, Fujise K. Profound negative regulatory effects by resveratrol on vascular smooth muscle cells. A role of p53-p21 (WAF1/CIP1) pathway. Biochem. Biophys. Res. Commun. 2003 311 : 546 52.
13. Zou J, Huang Y, Chen Q et al. Suppression of mitogenesis and regulation of cell cycle traverse by resveratrol in cultured smooth muscle cells. Int. J. Oncol. 1999 15 : 647 51.
14. Wang Z, Hsieh TC, Zhang Z, Ma Y, Wu JM. Identification and purification of resveratrol targeting proteins using immobilized resveratrol affinity chromatography. Biochem. Biophys. Res. Commun. 2004 323 : 743 9.
15. Long DJ, Jaiswal AK. NRH: Quinone oxidoreductase2 (NQO2). Chem. Biol. Interact. 2000 129 : 99 112.
16. Elbashir SM, Harborth J, Weber K, Tuschl T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 2002 26 : 199 213.
17. Birmingham A, Anderson E, Sullivan K et al. A protocol for designing siRNA with high functionality and specificity. Nat. Protocols 2007 9 : 2068 78.
18. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A. Rational siRNA design for RNA interference. Nat. Biotechnol. 2004 3 : 326 30.
19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) method. Methods 2001 25 : 402 8.
20. Vella F, Ferry G, Delagrange P, Boutin JA. NRH: Quinone reductase 2. An enzyme of surprises and mysteries. Biochem. Pharmacol. 2005 71 : 1 12.
21. Wallerath T, Deckert G, Ternes T et al. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 2002 106 : 1652 8.
22. Akishita M, Ouchi Y, Miyoshi H et al. Estrogen inhibits cuff-induced intimal thickening of rat femoral artery: Effects on migration and proliferation of vascular smooth muscle cells. Atherosclerosis 1997 130 : 1 10.
23. Pendurthi UR, Williams JT, Rao L. Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells. A possible mechanism for the cardiovascular benefits associated with moderate consumption of wine. Arterioscler. Thromb. Vasc. Biol. 1999 19 : 419 26.
24. Iijima K, Yoshizumi M, Hashimoto M et al. Red wine polyphenols inhibit proliferation of vascular smooth muscle cells and downregulate expression of cyclin A gene. Circulation 2000 101 : 805 11.
25. Chao HH, Juan SH, Liu JC et al. Resveratrol inhibits angiotensin II-induced endothelin-1 gene expression and subsequent proliferation in rat aortic smooth muscle cells. Eur. J. Pharmacol. 2005 515 : 1 9.
26. Oak MH, Chataigneau M, Keravis T et al. Red wine polyphenolic compounds inhibit vascular endothelial growth factor expression in vascular smooth muscle cells by preventing the activation of the p38 mitogen-activated protein. Arterioscler. Thromb. Vasc. Biol. 2003 23 : 1001 7.
27. Buryanovskyy L, Fu Y, Boyd M et al. Crystal structure of quinone reductase 2 in complex with resveratrol. Biochemistry 2004 43 : 11 417 26.
28. Guengerich FP. Metabolic activation of carcinogens. Pharmacol. Ther. 1992 54 : 17 61.
29. Breimer LH. Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: The role of DNA base damage. Mol. Carcinog. 1990 3 : 188 97.
30. Dhakshinamoorthy S, Jaiswal AK. Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H: Quinone oxidoreductase 1 gene. Oncogene 2001 20 : 3906 17.
31. McMahon M, Itoh K, Yamamoto M et al. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res. 2001 61 : 3299 307.
32. Li Y, Cao Z, Zhu H. Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress. Pharmacol. Res. 2006 53 : 6 15.
33. 2) leads to myeloid hyperplasia of bone marrow and decreases sensitivity to menadione toxicity. J. Biol. Chem. 2002 277 : 46 131 9.
34. Strassburg A, Strassburg CP, Manns MP, Tukey RH. Differential gene expression of NAD(P)H: Quinone oxidoreductase and NRH: Quinone oxidoreductase in human hepatocellular and biliary tissue. Mol. Pharmacol. 2002 61 : 320 5.